About Biotage
Biotage is a company based in Uppsala (Sweden) founded in 2009 was acquired by KKR in April 2025. The company has 11 employees as of April 06, 2024. Biotage has completed 6 acquisitions, including ATDBio, Astrea Bioseparations and Horizon Technology. Biotage offers products and services including Biotage® Initiator+, Biotage® Selekt, Biotage® V-10 Touch, and ISOLUTE® SCX-2. Biotage operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Curia and WuXi Biologics, among others.
- Headquarter Uppsala, Sweden
- Employees 11 as on 06 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biotage India Private Limited
- Date of Incorporation 11 Oct, 2017
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$643.79 K (USD)325.9as on Mar 31, 2020
-
Net Profit
-$19.45 K (USD)82.52as on Mar 31, 2020
-
EBITDA
-$5.64 K (USD)96.35as on Mar 31, 2020
-
Latest Funding Round
$2.35 K (USD), Grant
Jan 01, 2017
-
Investors
KKR
& 1 more
-
Employee Count
11
as on Apr 06, 2024
-
Investments & Acquisitions
ATDBio
& 5 more
-
Acquired by
KKR
(Apr 22, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biotage
Biotage offers a comprehensive portfolio of products and services, including Biotage® Initiator+, Biotage® Selekt, Biotage® V-10 Touch, and ISOLUTE® SCX-2.
Microwave synthesizer for efficient organic chemistry workflows
System for purification in drug discovery applications
Tool for sample evaporation and concentration processes
Product for solid phase extraction in analytical testing
People of Biotage
Unlock access to complete
Unlock access to complete
Software Development Team
16 people
Leadership Team
14 people
Sales and Marketing
11 people
Senior Team
6 people
Product Management Team
6 people
Human Resources and Administration
5 people
Finance and Accounting
4 people
Field Team
4 people
Unlock access to complete
Funding Insights of Biotage
Investors in Biotage
Biotage has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include KKR and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Biotage
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biotage
Biotage has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include ATDBio, Astrea Bioseparations and Horizon Technology.
Investment portfolio details for Biotage
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of oligonucleotides
|
Locked | Locked | 2005 | Locked | |
|
Molecular biology research products and automated extractors are developed.
|
Locked | Locked | 2002 | Locked | |
|
Manufacturer of polymeric separation resins
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Biotage
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Biotage
Detailed financials for Biotage
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biotage Comparisons
Peer comparison for Biotage
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biotage
Biotage operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Curia and WuXi Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Protein therapeutics are developed and manufactured by WuXi Biologics.
|
Detailed competitors of Biotage
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biotage
Complete news archive for Biotage
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biotage
Biotage was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Biotage is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.
As of Apr 06, 2024, the latest employee count at Biotage is 11.
Annual revenue of Biotage is $643.79K as on Mar 31, 2020.
Biotage was founded in 2009 in Uppsala, Sweden, and operates within the biotechnology sector focused on chemistry solutions. Products and services are offered in organic synthesis, analytical chemistry, and industrial resins, including separation technologies scaled from analysis to industrial levels. High-quality medical, analytical, and peptide chemistry solutions are provided for research and commercial applications. These are utilized by government authorities, academic institutions, pharmaceutical firms, and food companies.
Biotage offers Biotage® Initiator+, Biotage® Selekt, Biotage® V-10 Touch, and ISOLUTE® SCX-2.
Biotage has made 6 acquisitions, including ATDBio, Astrea Bioseparations, and Horizon Technology.
Biotage has 2 investors. Key investors include KKR, and European Union.